HealthTech

Synapxe, a Singapore-based health tech firm, has signed a collaboration agreement with Google Cloud to enhance its data and artificial intelligence (AI) platforms, HEALIX and Tandem, leveraging Google Cloud’s interoperable, industry-leading data and AI platform services.

ClavystBio, a life sciences investor and venture builder established by Temasek, and the Agency for Science, Technology and Research (A*STAR), Singapore's lead public sector research and development (R&D) agency, have signed a memorandum of understanding (MoU) to create and grow MedTech ventures in Singapore.

Quadria Capital, a Singapore-based premier healthcare-focused private equity firm, announced Monday the final close of its Fund III with $1.07 billion in total commitments, significantly exceeding its original $800 million target.

Temasek-based investment firm SeaTown Holdings International announced Wednesday its investment via SeaTown Private Capital Master Fund (SeaTown PCap Fund) in AddVita, a Singapore headquartered healthcare and life sciences distribution company.

Nuevocor, a Singapore-headquartered IND-stage biotechnology company developing cures for cardiomyopathies driven by aberrant mechanobiology, has announced the successful completion of $45 million Series B financing.

Creador, a Malaysia-based private equity firm in South and Southeast Asia, has announced the acquisition of up to 13 percent in FPT Long Chau Investment JSC (Long Chau), one of Vietnam’s leading pharmacy chains.

HealthMetrics, a Malaysia-based digital third-party administrator (TPA), announced the official launch of HealthMetrics Indonesia - uniting the longstanding expertise of Across Asia Assist Indonesia (AAA) with its advanced digital infrastructure to create a single, integrated digital TPA powerhouse poised to transform healthcare administration in Indonesia…

The Li Ka Shing Foundation (LKSF) and Temasek Trust (TT) have committed S$12 million ($8.99 million) to bring innovative non-invasive ultrasound-based histotripsy tumor clinical trials to Singapore.

Novotech, Singapore-headquartered full-service biotech specialist clinical research organization (CRO), announced that affiliates of GIC and Temasek have signed binding agreements to acquire a significant stake in the company, with the additional capital earmarked to accelerate its global growth.

Enya, a Singapore-based brand in sustainable period care, has secured strategic investment from 500 Global, alongside venture debt financing from Crusade Partners, to expand its consumer (B2C) and corporate (B2B) footprint across Asia and the Middle East.